Screening for adenylosuccinate lyase deficiency:: Clinical, biochemical and molecular findings in four patients

被引:22
作者
Castro, M
Pérez-Cerdá, C
Merinero, B
García, MJ
Bernar, J
Nagel, AG
Torres, J
Bermúdez, M
Garavito, P
Marie, S
Vincent, F
Van den Berghe, G
Ugarte, M [1 ]
机构
[1] Univ Autonoma Madrid, Dept Biol Mol, Ctr Diagnost Enfermedades Mol, E-28049 Madrid, Spain
[2] Hosp Ruber Int, Serv Genet & Neurol, Madrid, Spain
[3] Hosp Mostoles, Serv Pediat, Madrid, Spain
[4] Hosp Materno Infantil Santa Fe, Unidad Biol Procreat, Bogota, Colombia
[5] Int Inst Cellular & Mol Pathol, Physiol Chem Lab, B-1200 Brussels, Belgium
关键词
adenylosuccinate lyase (ADSL); purine metabolism; refractory epilepsy; mental retardation;
D O I
10.1055/s-2002-34493
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Adenylosuccinate lyase deficiency is an autosomal recessive defect of purine metabolism. Succinyladenosine (S-Ado) and succinylaminoimidazole carboxamide riboside (SAICAr) are the disease marker metabolites in physiological fluids. The Bratton-Marshall test for detection of SAICAr in urine has been added to the selective screening for inborn errors of metabolism that is carried out in our lab. During the last three years, around 2000 patients have been screened by this method, resulting in the detection of four new cases with this disease. They all presented with severe psychomotor delay, hypotonia and refractory epilepsy since the neonatal period. The S-Ado/SAICAr ratio in cerebrospinal fluid was below 2, indicating that they correspond to the most severe form of the disease. New missense mutations were found in a heterozygous fashion in three patients. The study of purines in all patients with neurological disease of unknown etiology is highly recommended.
引用
收藏
页码:186 / 189
页数:4
相关论文
共 16 条
[1]  
BOWLING FG, 2000, J INHER METAB S1, V23, P381
[2]   Neurologic aspects of adenylosuccinate lyase deficiency [J].
Ciardo, F ;
Salerno, C ;
Curatolo, P .
JOURNAL OF CHILD NEUROLOGY, 2001, 16 (05) :301-308
[3]  
JAEKEN J, 1984, LANCET, V2, P1058
[4]  
Kohler M, 1999, Eur J Paediatr Neurol, V3, P3, DOI 10.1053/ejpn.1999.0172
[5]   Identification and determination of succinyladenosine in human cerebrospinal fluid [J].
Krijt, J ;
Kmoch, S ;
Hartmannová, H ;
Havlícek, V ;
Sebesta, I .
JOURNAL OF CHROMATOGRAPHY B, 1999, 726 (1-2) :53-58
[6]   DETECTION OF 5'-PHOSPHORIBOSYL-4-(N-SUCCINYLCARBOXAMIDE)-5-AMINOIMIDAZOLE IN URINE BY USE OF THE BRATTON-MARSHALL REACTION - IDENTIFICATION OF PATIENTS DEFICIENT IN ADENYLOSUCCINATE LYASE ACTIVITY [J].
LAIKIND, PK ;
SEEGMILLER, JE ;
GRUBER, HE .
ANALYTICAL BIOCHEMISTRY, 1986, 156 (01) :81-90
[7]  
Marie S, 2000, PRENATAL DIAG, V20, P33, DOI 10.1002/(SICI)1097-0223(200001)20:1<33::AID-PD751>3.0.CO
[8]  
2-3
[9]  
Marie S, 1999, HUM MUTAT, V13, P197, DOI 10.1002/(SICI)1098-1004(1999)13:3<197::AID-HUMU3>3.0.CO
[10]  
2-D